We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen Rep’s Nucynta Statements Spur DDMAC Untitled Letter
Janssen Rep’s Nucynta Statements Spur DDMAC Untitled Letter
January 13, 2012
Janssen Pharmaceuticals recently received an untitled letter after a company representative was overheard making unsupported statements about pain drug Nucynta.